XPO1 and cancer: Future studies should evaluate the role of these inhibitors in cancer cells to determine if a mechanism of cell death is SINE-induced nuclear retention of CRM1, leading to microtubule, kinetochore, and centrosome dysregulation, and thus activation of the apoptotic pathway.